The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Projected compound annual growth rate (CAGR) of general anesthesias from 2015 to 2025
Global CAGR forecast general anesthetics 2015-2025, by drug type
This statistic displays the projected global CAGR for the period between 2015 and 2025 for general anesthetics. During this period, Propofol is expected to register a *** percent CAGR. As of 2015, it accounted for **** percent of the global general anesthesia drugs market.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Global propofol market size 2013, by region
- Premium Statistic U.S. market size of propofol 2010-2013
- Premium Statistic Europe: forecast of top selling pharmaceuticals in 2022, by trade name
- Basic Statistic Retail price increase of geriatric drugs in the U.S. in 2020, by manufacturer
- Basic Statistic Cough and cold self-medication market sales in Europe by country 2020
- Premium Statistic Canadian pharmaceutical exports and imports 2004-2024
- Basic Statistic Total value of pharmaceutical sales in Iceland 1980-2021
- Basic Statistic Total value of pharmaceutical sales in Switzerland 1987-2024
- Premium Statistic Europe: total pharmaceutical market sales forecast 2012-2022
- Premium Statistic Market value of non-prescription drugs in Italy 2001-2023
About the region
10
- Premium Statistic Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Premium Statistic Annual cost of MS drugs by select countries 2013-2014
- Basic Statistic Outlook for top narcolepsy products in the global market 2020-2026
- Basic Statistic Global medicines spending share by product type forecast 2028
- Premium Statistic Global consumption of major opium alkaloids and derivatives 2014-2023
- Premium Statistic Extraction of global morphine from poppy straw by type 2014-2023
- Basic Statistic Coca leaf utilization globally 2014-2023
- Premium Statistic Manufacture of global synthetic opioids by type 2013-2023
- Premium Statistic Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Premium Statistic Osteoporosis drug sales worldwide 2016-2025, by country
Selected statistics
10
- Basic Statistic Sales value of pharmaceuticals in Sweden 2013-2024
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
- Premium Statistic Total worldwide prescription drug revenue - projection 2018-2032
- Basic Statistic Country comparison in spending on medicine 2026
- Premium Statistic Global spending on medicines 2019-2029
- Premium Statistic Regional pharmaceutical market revenue worldwide 2024
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Basic Statistic Average length of a clinical trial cycle 2020-2024
- Basic Statistic Rate of return on biopharma R&D late-stage pipeline 2013-2025
- Basic Statistic Net sales of Recipharm 2009-2024
Other regions
10
- Premium Statistic Top specialty drug pharmacies in the U.S. by revenue 2025
- Premium Statistic Public drug program spending for seniors in Canada by top drug classes 2022
- Premium Statistic Annual cost of MS drugs in the United States from approval date to 2013
- Basic Statistic Usage rate of top drug classes prescribed to seniors in Canada by age 2021
- Basic Statistic Hydrochlorothiazide out-of-pocket cost U.S. 2004-2023
- Premium Statistic Number of drug shortages in Canada in selected months 2017-2020
- Basic Statistic Distribution of reasons for drug shortages in Canada 2017-2020
- Basic Statistic Distribution of beneficiaries number for drug shortages in Canada 2017-2020
- Basic Statistic Rates of drug shortages in Canada by manufacturer number 2019/2020
- Basic Statistic Rates of drug shortages in Canada by formulation 2019/2020
Related statistics
10
- Premium Statistic Top specialty drug pharmacies in the U.S. based on market share 2025
- Premium Statistic Distribution of public drug plan spending for drug shortages in Canada 2017-2020
- Premium Statistic Top 10 expensive drugs in Canada by annual cost per beneficiary 2021/2022
- Premium Statistic Potassium chloride out-of-pocket price U.S. 2004-2023
- Premium Statistic Amoxicillin out-of-pocket cost in the U.S. 2004-2023
- Basic Statistic Acetaminophen out of pocket price U.S. 2004-2023
- Premium Statistic Acetaminophen/hydrocodone out of pocket price U.S. 2004-2023
- Basic Statistic Losartan out of pocket price U.S. 2004-2023
- Premium Statistic Lisinopril out-of-pocket cost U.S. 2004-2023
- Basic Statistic Metformin out of pocket price U.S. 2004-2023
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Future Market ÌÇÐÄÆƽâ°æ. (September 4, 2015). Projected compound annual growth rate (CAGR) of general anesthesias from 2015 to 2025 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 03, 2026, from /statistics/537474/cagr-outlook-of-general-anesthesias-by-drug-type/
Future Market ÌÇÐÄÆƽâ°æ. "Projected compound annual growth rate (CAGR) of general anesthesias from 2015 to 2025." Chart. September 4, 2015. ÌÇÐÄÆƽâ°æ. Accessed August 03, 2026. /statistics/537474/cagr-outlook-of-general-anesthesias-by-drug-type/
Future Market ÌÇÐÄÆƽâ°æ. (2015). Projected compound annual growth rate (CAGR) of general anesthesias from 2015 to 2025. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 03, 2026. /statistics/537474/cagr-outlook-of-general-anesthesias-by-drug-type/
Future Market ÌÇÐÄÆƽâ°æ. "Projected Compound Annual Growth Rate (Cagr) of General Anesthesias from 2015 to 2025." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 4 Sep 2015, /statistics/537474/cagr-outlook-of-general-anesthesias-by-drug-type/
Future Market ÌÇÐÄÆƽâ°æ, Projected compound annual growth rate (CAGR) of general anesthesias from 2015 to 2025 ÌÇÐÄÆƽâ°æ, /statistics/537474/cagr-outlook-of-general-anesthesias-by-drug-type/ (last visited August 03, 2026)
Projected compound annual growth rate (CAGR) of general anesthesias from 2015 to 2025 [Graph], Future Market ÌÇÐÄÆƽâ°æ, September 4, 2015. [Online]. Available: /statistics/537474/cagr-outlook-of-general-anesthesias-by-drug-type/
Advertisement